Automation Gathers Pace in the Western European Liquid Handling Market
The escalating need for high throughput data is accelerating the shift towards automation in the Western European liquid handling market. Government investments in the development of bioclusters, as well as R&D centres for various drug discovery applications, are opening up opportunities for liquid handling companies in the region.
New analysis from Frost & Sullivan, Western European Liquid Handling Market, finds that the market earned revenues of $525 million in 2014 and estimates this to reach $890.7 million in 2021. Manual liquid handing systems discussed in this study include pipettes and consumables such as pipette tips and liquid containers. Automated instruments include all electronic pipettes and automated bench-top instruments.
Since most life science applications require sterile methods of handling liquids, non-contact dispensing is becoming an essential part of research laboratories.
• Researchers are promoting automated technologies such as acoustics and gas drive to eliminate contamination.
• Researchers are also working on super paramagnetic beads and a spatial light modulator for processing a large array of droplets.
• The advent of high-density microplate formats such as 384 and 1536 wells has enabled the screening of more compounds without extra cost for reagents.
“Laboratories prefer automated liquid handling systems, which can significantly reduce working hours for personnel,” said Frost & Sullivan Healthcare Senior Research Analyst Srinivas Sashidhar. “However, market participants must overcome several shortfalls before large scale laboratory automation is possible.”
For instance, the lack of open standards in product development and data transfer affects the compatibility between different components. As integration complexity grows, software compatibility too becomes a challenge. Further, the high price of automation equipment, along with laboratory consolidation across Europe compels laboratories to rethink liquid handling equipment purchases.
“Manufacturers must build automated equipment and accessories that are flexible for use with different liquid handling systems,” suggested Sashidhar. “Collaboration with reagent manufacturers will help create a greater number of validated protocols and widen the scope for expansion in the Western European liquid handling market.”
Western European Liquid Handling Market is part of the Life Sciences Growth Partnership Service programme.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance